SK hynix’s $29 Billion Nasdaq Listing: A Seoul View of the SKHY Debut

by

Published July 9, 2026, 15:40 KST — the evening before the scheduled debut. Figures are as of the July 9 Seoul close unless noted.

On Friday, July 10, SK hynix — the world’s second-largest memory chipmaker and the dominant supplier of the high-bandwidth memory (HBM) that powers AI accelerators — is set to begin trading on the Nasdaq under the ticker SKHY. The company plans to raise about $29 billion through American depositary receipts, which would make this the largest-ever initial U.S. stock sale by a foreign company, per CNBC — ahead of Alibaba’s 2014 record.

Most of the English-language coverage approaches this from the U.S. side: how to buy the ADR, how it compares to Micron. This piece looks at it from Seoul — what the listing means for the Korean-listed shares (KRX: 000660), for the KOSPI, and for the foreign investors who have been trading this stock through one of the most violent stretches in recent Korean market history.

The deal in one table

Item Detail
Listing date July 10, 2026 (U.S. session)
Venue / ticker Nasdaq Global Select Market / SKHY
Size ~$29 billion in ADRs — largest foreign U.S. listing on record
Use of proceeds ~₩31T first fab at the Yongin semiconductor cluster; ~₩19T P&T7 advanced-packaging fab in Cheongju; ~₩12T EUV lithography equipment
Strategic position Roughly 60% of the global HBM market, the memory segment at the heart of AI data-center buildouts

The proceeds breakdown is the tell: this is not a cash-out but a capex raise. Yongin is the largest semiconductor cluster project in Korea, and HBM capacity — plus the advanced packaging that HBM requires — is exactly where the AI supply bottleneck sits.

The Seoul context the U.S. coverage misses

SKHY is not debuting into calm waters. The Seoul-listed shares have roughly tripled over the past six months on the AI memory cycle, hitting a record high near ₩2.92 million in late June. Then came the July correction: the KOSPI dropped 7.89% in a single session on July 3, triggering a sidecar (program-trading halt), and SK hynix pulled back roughly 25% from its record high before rebounding more than 4% on July 9 to about ₩2.17 million.

The flow data behind that correction is worth knowing before the ADR starts trading. By our tracking of exchange investor-type data, foreign investors sold roughly ₩28 trillion (about $19 billion) of Korean stocks net over eight consecutive sessions from late June through July 7 — semiconductors bore the brunt — and then flipped to net buying on July 8 and 9, right as domestic retail capitulated and the market stabilized. In other words: the marginal global investor was dumping Korea two weeks ago and started buying back this week, days before a $29 billion slice of the market’s second-largest company hits their home exchange.

What the ADR changes for the Seoul shares — and what it doesn’t

  • Prices will stay linked. ADRs represent underlying ordinary shares, and conversion arbitrage keeps the two prices tethered. SKHY will not develop a life fully independent of 000660 — but small premiums and discounts will open and close across the 13-hour time-zone gap, and debut-day pricing versus the Seoul close is the first thing professionals will check.
  • New shares mean dilution — funded dilution. The raise reportedly comes from newly issued shares underlying the ADRs. Existing holders are diluted, but in exchange the Yongin buildout is essentially pre-funded, removing years of financing overhang.
  • Liquidity migration is the open question. Seoul currently hosts all of the stock’s liquidity. If a meaningful share of daily volume moves to Nasdaq over time — as happened with some dual-listed names elsewhere — the Seoul session could increasingly take its cue from the prior U.S. session, not the other way around.
  • The won still matters. Dollar-based SKHY buyers carry Korean-won economics inside the ADR. With USD/KRW trading above 1,500 during the recent stress — historically a level associated with currency strain — the FX line will be a real component of ADR returns, as of July 2026.
  • Index treatment is worth watching. How index providers and passive funds handle the new share count, and whether any weight adjustments follow in Korean and global benchmarks, will unfold over the coming reviews rather than on day one.

The bigger signal: the “Korea discount” experiment

Korean equities have long traded at a valuation discount to global peers — attributed variously to governance, geopolitics, and limited foreign accessibility. A U.S. listing of this size is the most aggressive attempt yet by a Korean issuer to close that gap by going directly to the world’s deepest capital pool. The nearest precedent is Coupang’s 2021 NYSE listing, but that was a company with no Seoul listing at all. SK hynix is different: a KOSPI heavyweight adding a second, larger-market venue. If SKHY sustains a valuation premium over the Seoul line, expect the “who’s next?” conversation — and pressure on other Korean large caps to follow — to start immediately.

What to watch on debut day

  1. Pricing versus Seoul parity. Where SKHY opens and closes relative to the FX-adjusted Seoul close on July 10.
  2. Allocation and volume. Whether the $29 billion is absorbed cleanly after a month in which global investors were net sellers of Korea.
  3. The Seoul session reaction on Monday, July 13. The first Seoul trading day with a live U.S. price to anchor against.
  4. Foreign flows in the ordinary shares. Whether the July 8–9 return of foreign buying extends through listing week.

FAQ

How do SKHY ADRs relate to the Seoul-listed shares (000660)?

Each ADR represents underlying SK hynix ordinary shares held on deposit. Conversion between the two keeps prices closely linked after fees and FX. You are economically buying the same company either way.

Does the Nasdaq listing remove the reason to trade the Seoul shares?

No. The Seoul line remains the primary listing, the largest liquidity pool at least initially, and the venue where Korean institutional and retail flow — a major driver of this stock — actually trades.

Why raise in the U.S. rather than in Seoul?

Scale and valuation. A ~$29 billion raise is enormous relative to daily Korean market capacity, and U.S. AI-infrastructure investors have shown the deepest appetite — and paid the highest multiples — for HBM exposure.

Sources

Disclaimer: This is an information and analysis publication, not investment advice. See our Methodology for data sources, standards, and our corrections policy.